Posted September 09, 2008 in Blog, Plastic Surgery in the News, Uncategorized
Lumigan 0.03%, manufactured by Allergan as a glaucoma eye drop is gaining popularity as an eye lash enhancer. As noted below in the “warnings” section, one of the side effects is the growth of eyelashes. Patients are seeing imrpovement as soon as 3 weeks. The product is available from physicians by prescription only.
Instructions for use for eyelash growth:
Remove Lumigan dropper cap and dip eyeliner brush into bottle. Apply with eyeliner brush as you would eyeliner, once daily until lashes are desired length (it may take 1-3 months to achieve the desired length), then once weekly for maintenance. If irritation occurs, stop for 1 week then start again every other day. Rinse after each use and keep brush in clean baggie or replace cap over brush. If you feel you have experienced an allergic reaction, stop using this medicine and inform your doctor.
Warnings:
Lumigan® (bimatoprost ophthalmic solution) 0.03% has been reported to cause changes to pigmented tissues. When used for glaucoma as eye drops on the eye, the most frequently reported changes have been increased pigmentation of the iris (the colored portion of the eye), periorbital tissue (eyelid) and eyelashes, and growth of eyelashes. Pigmentation is expected to increase as long as Lumigan® is administered. After discontinuation of Lumigan® pigmentation of the iris is likely to be permanent while pigmentation of the periorbital tissue and eyelash changes have been reported to be reversible in some patients. Patients who receive treatment should be informed of the possibility of increased pigmentation. The effects of increased pigmentation beyond 5 years are not known.
For additional Important Information about Lumigan® call 818 501-face.
